WB is selling at $15, page-9

Silverchair, I am glad you are still closely tracking the Disc Medicine/Clinuvel paradox. Since you brought it up a while back, I have also been following it with great interest. I hope at some point you put together a database of some kind showing the ridiculous disparity between Clinuvel and Disc Medicines share price, volume, market cap, debt, cash on hand, earnings, and future pipeline. In my personal opinion it is an excellent case study in pump and dump schemes, shorting and market manipulation. I also believe it clearly highlights why Clinuvel needs to increase their marketing presence, and especially their US ADR status which I believe will improve the daily bid/ask spread, liquidity and to help increase the pool of available investors. Right now we are in a position where one or a few hedge funds have free reign over the daily stock activity. More available investors, more liquidity and more transparency are probably the only things that will help.